PBH Earnings & Financial Statements
Prestige Consumer Healthcare Inc.
$47.40
-$0.17(-0.36%)
52
Overall
80
Value
36
Tech
42
Quality
Market Cap
$2.20B
Volume
134.99K
52W Range
$42.62 - $71.07
Target Price
$60.00
PBH earnings and financial statements: Prestige Consumer Healthcare Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
PBH Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Cost of revenue | - | $503.30M | - | - | $466.17M |
| Operating income | $309.41M | $336.77M | $342.43M | -$22.41M | $329.92M |
| EBITDA | $332.90M | $363.75M | $379.10M | $12.24M | $363.07M |
| Net income | $190.30M | $214.60M | $209.34M | -$82.31M | $205.38M |
| EPS (diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B |
| Total liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B |
| Shareholders’ equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B |
| Cash and equivalents | $63.87M | $97.88M | $46.47M | $58.49M | $27.18M |
| Long-term debt | $1.03B | $1.04B | $1.13B | $1.36B | $1.50B |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $257.63M | $251.51M | $248.93M | $229.72M | $259.92M |
| Capital expenditure | -$11.18M | -$8.22M | -$9.55M | -$7.78M | -$9.64M |
| Free cash flow | $246.45M | $243.29M | $239.38M | $221.93M | $250.28M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PBH | $47.40 | -0.4% | 134.99K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prestige Consumer Healthcare Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW